April 03, 2026
April 03, 2026
HER2CLIMB-05 Study: Tucatinib Enhances Progression-Free Survival as First-Line Maintenance for HER2-Positive Metastatic Breast Cancer
April 03, 2026
Acoramidis Linked to Lower Mortality Through 54 Months
April 03, 2026
ADA Member Advantage-endorsed CyraCom joins Propio Language Services
Latest Headlines
View More
April 03, 2026
Nonoperative Care Resolves Pediatric Duodenal Obstruction
April 03, 2026
Acoramidis Linked to Lower Mortality Through 54 Months
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Trending Now
1
Opioid Prescribing Trends After Guidelines
2
FDA Approves Lilly’s Foundayo Oral GLP-1 Pill
3
Mammography AI Spots Vascular Signals
4
Artificial Tears Reduce Dryness Symptoms in 1-Month Study
5
Top 10 States With the Most Favorable Tax Climate for Physicians
6
Botulinum Toxin Evaluated in Digital Ischemia
Conference Coverage
2026 ASCO GI
American College of Cardiology's 75th Annual Scientific Session & Expo
April 03, 2026
Acoramidis Linked to Lower Mortality Through 54 Months
April 01, 2026
Evolocumab Reduced CV Events in Diabetes
April 01, 2026
Tirzepatide Linked to Lower Cardiorenal Events
Clinical Guidelines
View More
Commentary & Perspectives
View More
April 03, 2026
Was the GLP-1 Problem Always Cost?
April 02, 2026
Genomic Data Tracks Measles Spread
April 02, 2026
Honoring Chromatography Educator Peter W. Carr (1944–2025)
FDA & Government News
View More
April 02, 2026
CDC Lists Dozens of Infectious Disease Tests as Unavailable
April 02, 2026
USDA Alerts on Lead in Walmart Chicken Nuggets
April 02, 2026
Genomic Data Tracks Measles Spread
April 01, 2026
FDA Approves Lilly’s Foundayo Oral GLP-1 Pill
Business Management
View More
March 31, 2026
